CELLPHIRE THERAPEUTICS Trademark

Trademark Overview

On Thursday, November 21, 2019, a trademark application was filed for CELLPHIRE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CELLPHIRE THERAPEUTICS trademark a serial number of 88701790. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Cellphire, Inc.. The CELLPHIRE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Blood platelets and other blood components for medical use; chemical reagents comprising blood platelets and other blood components for medical or veterinary purposes
cellphire therapeutics

General Information

Serial Number88701790
Word MarkCELLPHIRE THERAPEUTICS
Filing DateThursday, November 21, 2019
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6839878
Registration DateTuesday, September 6, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements

Description of MarkThe mark consists of the stylized word "CELLPHIRE" above the stylized word "THERAPEUTICS". A cell design formed by two stylized curved bars appears above and below the letters "CELL".
Goods and ServicesBlood platelets and other blood components for medical use; chemical reagents comprising blood platelets and other blood components for medical or veterinary purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 29, 2019
Primary Code005
First Use Anywhere DateFriday, February 18, 2022
First Use In Commerce DateFriday, February 18, 2022

Trademark Owner History

Party NameCellphire, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameCellphire, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameCellphire, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, August 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 25, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 25, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 5, 2022STATEMENT OF USE PROCESSING COMPLETE
Friday, July 1, 2022USE AMENDMENT FILED
Friday, July 1, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 19, 2022SOU EXTENSION 3 GRANTED
Tuesday, March 8, 2022SOU EXTENSION 3 FILED
Tuesday, April 12, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, April 12, 2022EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 12, 2022PETITION TO REVIVE-GRANTED
Tuesday, April 12, 2022TEAS PETITION TO REVIVE RECEIVED
Monday, April 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 11, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 22, 2022CORRECTED NOA E-MAILED
Saturday, March 19, 2022DIVISIONAL PROCESSING COMPLETE
Monday, March 7, 2022DIVISIONAL REQUEST RECEIVED
Friday, March 18, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 7, 2022TEAS REQUEST TO DIVIDE RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 2 FILED
Tuesday, September 7, 2021TEAS EXTENSION RECEIVED
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021SOU EXTENSION 1 GRANTED
Monday, January 25, 2021SOU EXTENSION 1 FILED
Monday, January 25, 2021TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 10, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 9, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 8, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 8, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 4, 2020NON-FINAL ACTION E-MAILED
Thursday, June 4, 2020NON-FINAL ACTION WRITTEN
Thursday, May 28, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 12, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, April 23, 2020ASSIGNED TO LIE
Friday, April 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 17, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 26, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 26, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 25, 2020ASSIGNED TO EXAMINER
Saturday, November 30, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 25, 2019NEW APPLICATION ENTERED

Related Keywords

therapeutics cellphire blood components medical other platelets veterinary purposes reagents chemical comprising